Journal
CANCER MANAGEMENT AND RESEARCH
Volume 13, Issue -, Pages -Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S300195
Keywords
melanoma; receptor tyrosine kinase; USP8; therapy resistance
Categories
Funding
- Hubei University of Medicine [2017-43]
Ask authors/readers for more resources
This study demonstrated that the overexpression of USP8 in melanoma is associated with increased cell activities and resistance to therapeutic drugs. Inhibition of USP8 activity can lead to reduced expression of multiple oncogenic RTKs and disruption of downstream survival signaling pathways, promoting apoptosis in melanoma cells. This suggests that USP8 may be a potential target for sensitizing melanoma cells to therapy.
Introduction: The hyperactivation of receptor tyrosine kinase (RTK)-mediated pathways plays an important role in melanoma progression and resistance to therapy. The ubiquitin-specific protease 8 (USP8) is a deubiquitinating enzyme and its inhibition induces degradation of RTKs. This work explored the expression and role of USP8 in melanoma. Methods: ELISA and qPCR were performed to assess USP8 expression in melanoma tissues and cells, as well as their normal counterparts. Cellular proliferation, migration and apoptosis assays were performed to determine USP8 functions in three melanoma cell lines. Western blot was performed to analyze RTK signaling in melanoma cells after USP8 inhibition. Results: mRNA and protein level of USP8 were higher in melanoma cells than normal melanocytes. Higher USP8 expression was also found in tumors in the majority of melanoma patients. USP8 expression was not associated with clinicopathological features, such as age, disease stage, histology, ulceration and BRAF status. Functional analysis demonstrated that USP8 overexpression promoted melanoma cell activities and alleviated the inhibitory effects of therapeutic drugs. In contrast, USP8 knockdown suppressed melanoma cell growth, survival and migration, and augmented the inhibitory effects of therapeutic drugs. Mechanism studies revealed that USP8 inhibition remarkably reduced the expression level of multiple oncogenic RTKs, including c-Met, Kit, EGFR and GPCR. Consistently, RTK-mediated downstream pathways were disrupted in USP8-depleted cells, leading to the increased level of pro-apoptotic proteins and decreased level of anti-apoptotic proteins. Conclusion: Inhibition of USP8 activity is a novel sensitizing strategy to overcome therapy resistance in melanoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available